Search Results for " Lenvatinib "
Lenvatinib Related Products
Lenvatinib is an anticancer medication used to treat thyroid, kidney, and liver cancers. It functions as a receptor tyrosine kinase inhibitor and is indicated for metastatic thyroid cancer, advanced renal cell carcinoma (when used in combination with everolimus), and unresectable hepatocellular carcinoma.
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Lenvatinib, pharmacopeial and non-pharmacopeial Lenvatinib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Lenvatinib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Lenvatinib-related products are thoroughly characterized. Lenvatinib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.